Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-24 @ 11:16 PM
NCT ID:
NCT02360956
Eligibility Criteria:
Inclusion Criteria:
* coronary artery stenosis between 30% and 70% determined by CCTA in essential hypertension patients
* resting diastolic blood pressure (DBP) between 90 and 110 mmHg
* type A and B for coronary artery vascular lesions
Exclusion Criteria:
* secondary hypertension
* coronary artery stenosis less than 30% or greater than 70% determined by CCTA
* contraindications to treatment with olmesartan medoxomil (allergy, glaucoma, digestive ulcer, is currently taking phosphodiesterase-5 inhibitor)
* resting systolic blood pressure (SBP) \> 200 mmHg or resting diastolic blood pressure (DBP) \> 110 mmHg
* Severe calcification, distortion or type C for coronary artery vascular lesions
* pregnancy
* unwillingness or inability to provide informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02360956
Study Brief:
Protocol Section:
NCT02360956